ScholarIQanswers from OpenAlex

Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System

PaperCitations, authors & open-access status

Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System have?

ScholarIQcitation count

Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System has 15 citations in the OpenAlex counts ScholarIQ stores.

When was Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System published?

ScholarIQyear

Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System has 2022 year in the ScholarIQ index.

What is the open-access status of Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System?

ScholarIQoa status

Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System has gold oa status in the ScholarIQ index.

What is the DOI of Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System?

ScholarIQdoi

The DOI for Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System is on the source record.

What is the PMID of Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System?

ScholarIQpmid

The PMID for Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System is on the source record.

What is the OpenAlex record for Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System?

ScholarIQopenalex

The OpenAlex for Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial